Jan. 22, 2021 12:00 UTC
Bank of America Announces Redemption of €2.0 Billion of Floating Rate Senior Notes, due February 7, 2022 and €1.25 Billion of 0.736% Fixed/Floating Rate Senior Notes, due February 7, 2022
Bank of America Announces Redemption of €2.0 Billion of Floating Rate Senior Notes, due February 7, 2022 and €1.25 Billion of 0.736% Fixed/Floating Rate Senior Notes, due February 7, 2022 Jan. 22, 2021 12:00 UTC Bank of America Announces Redemption of €2.0 Billion of Floating Rate Senior Notes, due February 7, 2022 and €1.25 Billion of 0.736% Fixed/Floating Rate Senior Notes, due February 7, 2022 CHARLOTTE, N.C.--(BUSINESS WIRE)-- Bank of America Corporation announced today that it will redeem on February 7, 2021 (i) all €2,000,000,000 principal amount outstanding of its Floating Rate Senior Notes, due February 7, 2022 (ISIN: XS1560862580; Common Code: 156086258) (the "
Jan. 22, 2021 14:01 UTC
Vertex to Announce Fourth-Quarter 2020 Financial Results on February 1
Vertex to Announce Fourth-Quarter 2020 Financial Results on February 1 Jan. 22, 2021 14:01 UTC Vertex to Announce Fourth-Quarter 2020 Financial Results on February 1 BOSTON--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its fourth-quarter 2020 financial results on Monday, February 1, 2021 after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET. To access the call, please dial (866) 501-1537 (U.S.) or +1 (720) 545-0001 (International). The conference call will be webcast live and a link to the webcast can be accessed through Vertex's website at www.vrtx.com in the "Investors" section. To ensure a ti
Jan. 22, 2021 12:00 UTC
Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer
Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer Jan. 22, 2021 12:00 UTC Spectrum Pharmaceuticals Announces Two Oral Presentations at Upcoming IASLC 2020 World Conference on Lung Cancer HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced an oral presentation on updated efficacy, safety, and dosing management of poziotinib from Cohorts 1 and 2 of the ZENITH20 clinical trial. In addition, Spectrum also announced an oral presentation on the structural classification of atypical EGFR mutations and their
Jan. 22, 2021 12:00 UTC
Housing Market Potential Expected to Build on Momentum in 2021, According to First American Potential Home Sales Model
Housing Market Potential Expected to Build on Momentum in 2021, According to First American Potential Home Sales Model Jan. 22, 2021 12:00 UTC Housing Market Potential Expected to Build on Momentum in 2021, According to First American Potential Home Sales Model —Twin housing market accelerants, record low mortgage rates and the demographic boost from millennials aging into their prime homebuying years, super-charged demand, says Chief Economist Mark Fleming— SANTA ANA, Calif.--(BUSINESS WIRE)-- First American Financial Corporation (NYSE: FAF), a leading global provider of title insurance, settlement services and risk solutions for real estate transactions, today released Fir
Jan. 22, 2021 13:00 UTC
Korn Ferry Expands Presence in Russia
Korn Ferry Expands Presence in Russia Jan. 22, 2021 13:00 UTC Korn Ferry Expands Presence in Russia Widely Regarded Consultants Joining Firm, Ushering in Broader Depth of Expertise and Diversified Solutions for Organizations in the Region LOS ANGELES--(BUSINESS WIRE)-- Korn Ferry (NYSE: KFY), a global organizational consulting firm, today announced the expansion of its presence in Russia with the addition of an experienced team of executive search and organizational consulting professionals. The addition of the new consultants will immediately increase Korn Ferry’s breadth and depth of capabilities and enhance Korn Ferry’s ability to impact clients in the region. Yaroslav G
Jan. 22, 2021 11:55 UTC
The GEO Group Announces Tax Treatment of 2020 Dividends
The GEO Group Announces Tax Treatment of 2020 Dividends Jan. 22, 2021 11:55 UTC The GEO Group Announces Tax Treatment of 2020 Dividends BOCA RATON, Fla.--(BUSINESS WIRE)-- The GEO Group, Inc. (NYSE: GEO) ("GEO") announced today the tax treatment of its 2020 dividend distributions. The following table summarizes, for income tax purposes, the nature of distributions paid to shareholders, presented on a per share basis, during the calendar year ended December 31, 2020. Shareholders are encouraged to consult with their own tax advisors as to their specific tax treatment of GEO distributions. Common Stock (CUSIP # 36162J106) Ordinary Dividends Capital Gains CUSIP RecordDa

Execution time: 0.3631 seconds
Layout: desktop